Abstract:BackgroundDyslipidemia is one of the four major risk factors for the development of cardiovascular disease, along with hypertension, smoking, and diabetic mellitus. This countrywide study aimed to determine the prevalence and patterns of dyslipidemia and to describe their characteristics using data from the Korean population visiting local clinics.MethodsWe retrospectively reviewed the lipid profiles (total cholesterol (TC), low-density lipoprotein cholesterol (LDLC), high-density lipoprotein cholesterol (HDLC), and triglycerides (TG)) and fasting plasma glucose (FPG) test results from Korean patients visiting local clinics during December 2023. Dyslipidemia was defined as having one or more of TC ≥200 mg/dl, LDLC ≥100 mg/dl, HDLC <40 mg/dl for males and <50 mg/dl for females, or TG ≥150 mg/dl (National Cholesterol Education Program, Adult Training Program III, 2002). Glucose levels are considered hyperglycemic if blood glucose ≥126 mg/dl. The subjects comprised 1,232 patients who visited 57 local clinics nationwide were included. Lipid profile tests (except LDLC) and FPG were performed on Hitachi008AS automatic biochemistry analyzer and the LDLC test was calculated by the Friedewald equation. Data for TG ≥400 mg/dL were excluded.ResultsThe study subject population comprised 610 males and 622 females aged 2 to 91 years. The overall prevalence of dyslipidemia was 53.3% (657/1,232), with 49.3% (301/657) males and 57.2 (356/657) females (p<0.001). TC, LDLC, and TG were high in 14.5% (95/657), 33.9% (184/657), and 23.6% (223/657) of patients, respectively; HDLC was low in 28.0% (155/657). The prevalence of dyslipidemia by age group was as follows: 2 to 19 years (36.4%, 4/11); 20 to 29 years (66.7%, 12/18); 30 to 39 years (52.5%, 52/99); 40 to 49 years (61.5%, 131/213); 50 to 59 years (57.0%, 167/293); 60 to 69 years (50.1%, 168/335); 70 to 79 years (48.4%, 91/188); 80 years or older, (42.7%, 32/75). There was a difference in the prevalence of dyslipidemia between the age group under 50 and the age group over 50 (p<0.001). The prevalence of dyslipidemia among males and females was TC (72.6% vs 28.4%), HDLC (55.4% vs 44.6%), LDLC (53.8% vs 46.2%), TG (42.6% vs 57.4%), respectively (p<0.001). Thirteen of the 1,232 patients had dyslipidemia accompanied by hyperglycemia. Seven of them had mixed dyslipidemia (including raised TC, LDLC, and TG (n=4), raised TG & Low HDLC (n=2), raised TC and LDLC (n=1)).ConclusionsThe prevalence of dyslipidemia in Korean patients visiting local clinics was 53.3% and differed by gender, age group, and lipid profile. Considering that the prevalence of dyslipidemia is higher in diabetic patients compared to patients without diabetes, additional studies targeting a large number of patients are needed to promote disease prevention and control.

Predictive cut-off values for the triglyceride-to-high-density lipoprotein cholesterol ratio to predict metabolic syndrome in the middle-aged Korean population

Clinical Usefulness Of Metabolic Risk Factors To Identify Young Asymptomatic Women Adults With Subclinical Atherosclerosis: A Cross-Sectional Study

The value of Apolipoprotein B/Apolipoprotein A1 ratio for metabolic syndrome diagnosis in a Chinese population: a cross-sectional study

The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans

Sex- and Age-Specific Optimal Anthropometric Indices As Screening Tools for Metabolic Syndrome in Chinese Adults

Trends in the prevalence of metabolic syndrome and its components in South Korea: Findings from the Korean National Health Insurance Service Database (2009-2013)

Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome

Optimal cutoff values for anthropometric indices of obesity as discriminators of metabolic abnormalities in Korea: results from a Health Examinees study

Harnessing Metabolic Indices as a Predictive Tool for Cardiovascular Disease in a Korean Population without Known Major Cardiovascular Event

Association between the Korean Healthy Diet Score and Metabolic Syndrome: Effectiveness and Optimal Cutoff of the Korean Healthy Diet Score

The single point insulin sensitivity estimator (SPISE) index as a predictor of metabolic syndrome in Korean adults

Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1

Prospective Associations of Serum Adiponectin, Leptin, and Leptin-Adiponectin Ratio with Incidence of Metabolic Syndrome: The Korean Genome and Epidemiology Study

A-217 Estimation of the Prevalence and the Patterns of Dyslipidemia in the Korean population

Prognostic Value of Triglyceride and Glucose Index for Incident Type 2 Diabetes beyond Metabolic Health and Obesity

Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio is a more powerful marker than TyG index for predicting metabolic syndrome in patients with type 2 diabetes mellitus

Metabolic syndrome clustering patterns and the association with cardiovascular disease among post-menopausal Korean women

Predicting metabolic syndrome by obesity- and lipid-related indices in mid-aged and elderly Chinese: a population-based cross-sectional study

Triglyceride-Glucose Index Predicts Cardiovascular Outcome in Metabolically Unhealthy Obese Population: A Nationwide Population-Based Cohort Study

Triglyceride and Glucose Index as an Optimal Predictor of Metabolic Syndrome in Lebanese Adults

METS-IR and all-cause mortality in Korean over 60 years old: Korean genome and epidemiology study-health examinees (KoGES-HEXA) cohorts